loader
Please Wait
Applying Filters...

Seqens Seqens

X

List of Active Pharmaceutical Ingredients (APIs) supplied/manufactured by Seqens

Client Virtual Booth
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 Abemaciclib (1)

02 Alimemazine (1)

03 Ammonium Lactate (1)

04 Apraclonidine Hydrochloride (1)

05 Articaine Hydrochloride (1)

06 Baclofen (1)

07 Cantharidin (1)

08 Cetirizine Dihydrochloride (1)

09 Ciclopirox (1)

10 Ciclopirox Olamine (1)

11 Cilostazol (1)

12 Cinacalcet Hydrochloride (1)

13 Cisatracurium Besylate (1)

14 Clascoterone (1)

15 Clomiphene Citrate (1)

16 Clonidine (1)

17 Desipramine Hydrochloride (1)

18 Efinaconazole (1)

19 Elacestrant (1)

20 Ensifentrine (1)

21 Esketamine Hydrochloride (1)

22 Fenofibrate (1)

23 Fexofenadine Hydrochloride (1)

24 Flumazenil (1)

25 Fluralaner (1)

26 Fluticasone Furoate (1)

27 Fluticasone Propionate (1)

28 Fulvestrant (1)

29 Ganaxolone (1)

30 Glycopyrrolate Tosylate (1)

31 Glycopyrronium Bromide (1)

32 Granisetron (1)

33 Granisetron Hydrochloride (1)

34 Halobetasol (1)

35 Heptaminol (1)

36 Imiquimod (1)

37 Ketamine Hydrochloride (1)

38 Lotilaner (1)

39 Mepenzolate Bromide (1)

40 Mepivacaine Hydrochloride (1)

41 Mequitazine (1)

42 Methimazole (1)

43 Midazolam (1)

44 Mifepristone (1)

45 Modafinil (1)

46 Mometasone Furoate (1)

47 Moxonidine (1)

48 Niraparib Tosylate (1)

49 Olopatadine Hydrochloride (1)

50 Oxeladin (1)

51 Oxybutynin (1)

52 Oxybutynin Hydrochloride (1)

53 Palonosetron (1)

54 Permethrin (1)

55 Pholcodine (1)

56 Pindolol (1)

57 Piperidolate Hydrochloride (1)

58 Podophyllotoxin (1)

59 Pralidoxime Chloride (1)

60 Praziquantel (1)

61 Promazine (1)

62 Propofol (1)

63 Pyridostigmine (1)

64 R-Ketamine (1)

65 Remimazolam (1)

66 Reproxalap (1)

67 Rocuronium Bromide (1)

68 Rotigotine (1)

69 Ruxolitinib Phosphate (1)

70 Sitagliptin Hydrochloride (1)

71 Sitagliptin Malate (1)

72 Sitagliptin Phosphate (1)

73 Sodium Phenylbutyrate (1)

74 Sparsentan (1)

75 Sugammadex Sodium (1)

76 Tamoxifen Citrate (1)

77 Tapinarof (1)

78 Tazarotene (1)

79 Temozolomide (1)

80 Tetrahydrozoline (1)

81 Timolol Maleate (1)

82 Tiotropium Bromide (1)

83 Tramadol Hydrochloride (1)

84 Trofinetide (1)

85 Troxerutin (1)

86 Umeclidinium Bromide (1)

87 Vamorolone (1)

88 Varenicline (1)

filter

01 Seqens (88)

filter

01 France (88)

Since its inception in 2003, Seqens has grown to become a global leader in pharmaceutical solutions and specialty ingredients. Seqens supports its customers in developing, scaling up and manufacturing drug substances from the pre-clinical phase to the commercial phase. It offers a large portfolio of APIs and proprietary products. Seqens also develo...
Since its inception in 2003, Seqens has grown to become a global leader in pharmaceutical solutions and specialty ingredients. Seqens supports its customers in developing, scaling up and manufacturing drug substances from the pre-clinical phase to the commercial phase. It offers a large portfolio of APIs and proprietary products. Seqens also develops custom solutions and ingredients for the most demanding industries, such as healthcare, electronics and cosmetics. Its unique range of technologies enables it to manufacture complex molecules for small- and large-scale demands. It operates 24 industrial plants and 10 R&D centres across the globe.
Since its inception in 2003, Seqens has grown to become a global leader in pharmaceutical solutions and specialty ingredients. Seqens supports its customers in developing, scaling up and manufacturing drug substances from the pre-clinical phase to the commercial phase. It offers a large portfolio of APIs and proprietary products. Seqens also develo...
Since its inception in 2003, Seqens has grown to become a global leader in pharmaceutical solutions and specialty ingredients. Seqens supports its customers in developing, scaling up and manufacturing drug substances from the pre-clinical phase to the commercial phase. It offers a large portfolio of APIs and proprietary products. Seqens also develops custom solutions and ingredients for the most demanding industries, such as healthcare, electronics and cosmetics. Its unique range of technologies enables it to manufacture complex molecules for small- and large-scale demands. It operates 24 industrial plants and 10 R&D centres across the globe.
Since its inception in 2003, Seqens has grown to become a global leader in pharmaceutical solutions and specialty ingredients. Seqens supports its customers in developing, scaling up and manufacturing drug substances from the pre-clinical phase to the commercial phase. It offers a large portfolio of APIs and proprietary products. Seqens also develo...
Since its inception in 2003, Seqens has grown to become a global leader in pharmaceutical solutions and specialty ingredients. Seqens supports its customers in developing, scaling up and manufacturing drug substances from the pre-clinical phase to the commercial phase. It offers a large portfolio of APIs and proprietary products. Seqens also develops custom solutions and ingredients for the most demanding industries, such as healthcare, electronics and cosmetics. Its unique range of technologies enables it to manufacture complex molecules for small- and large-scale demands. It operates 24 industrial plants and 10 R&D centres across the globe.
Since its inception in 2003, Seqens has grown to become a global leader in pharmaceutical solutions and specialty ingredients. Seqens supports its customers in developing, scaling up and manufacturing drug substances from the pre-clinical phase to the commercial phase. It offers a large portfolio of APIs and proprietary products. Seqens also develo...
Since its inception in 2003, Seqens has grown to become a global leader in pharmaceutical solutions and specialty ingredients. Seqens supports its customers in developing, scaling up and manufacturing drug substances from the pre-clinical phase to the commercial phase. It offers a large portfolio of APIs and proprietary products. Seqens also develops custom solutions and ingredients for the most demanding industries, such as healthcare, electronics and cosmetics. Its unique range of technologies enables it to manufacture complex molecules for small- and large-scale demands. It operates 24 industrial plants and 10 R&D centres across the globe.
Since its inception in 2003, Seqens has grown to become a global leader in pharmaceutical solutions and specialty ingredients. Seqens supports its customers in developing, scaling up and manufacturing drug substances from the pre-clinical phase to the commercial phase. It offers a large portfolio of APIs and proprietary products. Seqens also develo...
Since its inception in 2003, Seqens has grown to become a global leader in pharmaceutical solutions and specialty ingredients. Seqens supports its customers in developing, scaling up and manufacturing drug substances from the pre-clinical phase to the commercial phase. It offers a large portfolio of APIs and proprietary products. Seqens also develops custom solutions and ingredients for the most demanding industries, such as healthcare, electronics and cosmetics. Its unique range of technologies enables it to manufacture complex molecules for small- and large-scale demands. It operates 24 industrial plants and 10 R&D centres across the globe.
Since its inception in 2003, Seqens has grown to become a global leader in pharmaceutical solutions and specialty ingredients. Seqens supports its customers in developing, scaling up and manufacturing drug substances from the pre-clinical phase to the commercial phase. It offers a large portfolio of APIs and proprietary products. Seqens also develo...
Since its inception in 2003, Seqens has grown to become a global leader in pharmaceutical solutions and specialty ingredients. Seqens supports its customers in developing, scaling up and manufacturing drug substances from the pre-clinical phase to the commercial phase. It offers a large portfolio of APIs and proprietary products. Seqens also develops custom solutions and ingredients for the most demanding industries, such as healthcare, electronics and cosmetics. Its unique range of technologies enables it to manufacture complex molecules for small- and large-scale demands. It operates 24 industrial plants and 10 R&D centres across the globe.
Since its inception in 2003, Seqens has grown to become a global leader in pharmaceutical solutions and specialty ingredients. Seqens supports its customers in developing, scaling up and manufacturing drug substances from the pre-clinical phase to the commercial phase. It offers a large portfolio of APIs and proprietary products. Seqens also develo...
Since its inception in 2003, Seqens has grown to become a global leader in pharmaceutical solutions and specialty ingredients. Seqens supports its customers in developing, scaling up and manufacturing drug substances from the pre-clinical phase to the commercial phase. It offers a large portfolio of APIs and proprietary products. Seqens also develops custom solutions and ingredients for the most demanding industries, such as healthcare, electronics and cosmetics. Its unique range of technologies enables it to manufacture complex molecules for small- and large-scale demands. It operates 24 industrial plants and 10 R&D centres across the globe.
Since its inception in 2003, Seqens has grown to become a global leader in pharmaceutical solutions and specialty ingredients. Seqens supports its customers in developing, scaling up and manufacturing drug substances from the pre-clinical phase to the commercial phase. It offers a large portfolio of APIs and proprietary products. Seqens also develo...
Since its inception in 2003, Seqens has grown to become a global leader in pharmaceutical solutions and specialty ingredients. Seqens supports its customers in developing, scaling up and manufacturing drug substances from the pre-clinical phase to the commercial phase. It offers a large portfolio of APIs and proprietary products. Seqens also develops custom solutions and ingredients for the most demanding industries, such as healthcare, electronics and cosmetics. Its unique range of technologies enables it to manufacture complex molecules for small- and large-scale demands. It operates 24 industrial plants and 10 R&D centres across the globe.
Since its inception in 2003, Seqens has grown to become a global leader in pharmaceutical solutions and specialty ingredients. Seqens supports its customers in developing, scaling up and manufacturing drug substances from the pre-clinical phase to the commercial phase. It offers a large portfolio of APIs and proprietary products. Seqens also develo...
Since its inception in 2003, Seqens has grown to become a global leader in pharmaceutical solutions and specialty ingredients. Seqens supports its customers in developing, scaling up and manufacturing drug substances from the pre-clinical phase to the commercial phase. It offers a large portfolio of APIs and proprietary products. Seqens also develops custom solutions and ingredients for the most demanding industries, such as healthcare, electronics and cosmetics. Its unique range of technologies enables it to manufacture complex molecules for small- and large-scale demands. It operates 24 industrial plants and 10 R&D centres across the globe.
Since its inception in 2003, Seqens has grown to become a global leader in pharmaceutical solutions and specialty ingredients. Seqens supports its customers in developing, scaling up and manufacturing drug substances from the pre-clinical phase to the commercial phase. It offers a large portfolio of APIs and proprietary products. Seqens also develo...
Since its inception in 2003, Seqens has grown to become a global leader in pharmaceutical solutions and specialty ingredients. Seqens supports its customers in developing, scaling up and manufacturing drug substances from the pre-clinical phase to the commercial phase. It offers a large portfolio of APIs and proprietary products. Seqens also develops custom solutions and ingredients for the most demanding industries, such as healthcare, electronics and cosmetics. Its unique range of technologies enables it to manufacture complex molecules for small- and large-scale demands. It operates 24 industrial plants and 10 R&D centres across the globe.
Post Enquiry
POST ENQUIRY